REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,508,848 | +51.2% | 223,976 | 0.0% | 0.05% | +37.8% |
| Q3 2022 | $5,629,000 | -17.3% | 223,976 | 0.0% | 0.04% | -5.1% |
| Q2 2022 | $6,807,000 | -7.2% | 223,976 | 0.0% | 0.04% | -7.1% |
| Q1 2022 | $7,337,000 | +24.2% | 223,976 | 0.0% | 0.04% | +44.8% |
| Q4 2021 | $5,906,000 | -73.8% | 223,976 | 0.0% | 0.03% | -70.7% |
| Q3 2021 | $22,534,000 | -28.9% | 223,976 | 0.0% | 0.10% | -28.8% |
| Q2 2021 | $31,699,000 | +42.0% | 223,976 | 0.0% | 0.14% | +43.3% |
| Q1 2021 | $22,330,000 | -19.4% | 223,976 | 0.0% | 0.10% | -6.7% |
| Q4 2020 | $27,688,000 | +434.4% | 223,976 | +321.1% | 0.10% | +395.2% |
| Q3 2020 | $5,181,000 | -40.7% | 53,183 | -5.0% | 0.02% | -46.2% |
| Q2 2020 | $8,734,000 | +8.1% | 55,983 | 0.0% | 0.04% | -22.0% |
| Q1 2020 | $8,081,000 | -3.5% | 55,983 | +36.6% | 0.05% | +11.1% |
| Q4 2019 | $8,378,000 | – | 40,983 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |